GUSELKUMAB

Clinical Indication

Treating active psoriatic arthritis after inadequate response to DMARDs

Comments

In line with NICE TA711

Date of classification

September 2021

Review date

September 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).